Autopsy report · NCT05203419

Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sponsor Decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 1 year 3 months before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Novartis Pharmaceuticals
Sponsor type: Industry
Conditions: Lupus Erythematosus, Systemic
Interventions: MHS552; Placebo
Participants: 8
Sites: 1
Countries: Germany

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.